Analogue-Based Drug Discovery III

János Fischer, C. Robin Ganellin, David P. Rotella

Research output: Book/ReportBookpeer-review

16 Scopus citations

Abstract

Most drugs are analogue drugs. There are no general rules how a new drug can be discovered, nevertheless, there are some observations which help to find a new drug, and also an individual story of a drug discovery can initiate and help new discoveries. Volume III is a continuation of the successful book series with new examples of established and recently introduced drugs. The major part of the book is written by key inventors either as a case study or a study of an analogue class. With its wide range across a variety of therapeutic fields and chemical classes, this is of interest to virtually every researcher in drug discovery and pharmaceutical chemistry, and -- together with the previous volumes -- constitutes the first systematic approach to drug analogue development.

Original languageEnglish
PublisherWiley-VCH
ISBN (Print)9783527330737
DOIs
StatePublished - 18 Dec 2012

Fingerprint

Dive into the research topics of 'Analogue-Based Drug Discovery III'. Together they form a unique fingerprint.

Cite this